Health

  • July 01, 2026

    Gov't Officials Tout Unprecedented Healthcare Fraud Push

    It's been an unprecedented year for healthcare fraud enforcement, senior government officials from the U.S. Justice Department and Department of Health and Human Services told conference attendees gathered in a ballroom Wednesday morning at the Midtown Hilton in Manhattan.

  • July 01, 2026

    Amgen Wins Order Blocking Colorado's Enbrel Price Cap

    Colorado is preliminarily blocked from enforcing its price cap on Amgen's rheumatoid arthritis drug Enbrel, a federal judge ruled Wednesday, saying the biotech company is likely to succeed on its claim that federal patent law preempts the state's effort to limit the price of patented medications.

  • July 01, 2026

    Conn. Justices Allow Death Damages Input After $8.5M Verdict

    The Connecticut Supreme Court will allow the Connecticut Defense Lawyers Association and the American Medical Association to weigh in on whether legally distinct damages are available for losing the ability to enjoy life's activities and for death itself as the justices consider an $8.5 million verdict against a knee surgeon's medical practice.

  • July 01, 2026

    Doc Asks To Seek Defamation Punitive Damages Against CNN

    A doctor has asked the Florida Supreme Court to lift a stay on his petition to seek punitive damages against CNN over a 2015 story about pediatric surgery mortality rates, citing the high court's recent decision that lowered the evidentiary bar to add punitive damages claims.

  • July 01, 2026

    TikTok Nears Deal Ahead Of 2nd Social Media Addiction Trial

    A plaintiff who alleges he became harmfully addicted to major social media platforms as a child and whose case is set to be the second bellwether trial later this month out of thousands of similar cases pending in Los Angeles court has reached a settlement in principle with TikTok, his counsel told Law360 on Wednesday.

  • July 01, 2026

    8th Circ. Keeps Missouri's 340B Contract Pharmacy Law Alive

    The Eighth Circuit declined Wednesday to temporarily block a Missouri law that bars drugmakers from imposing restrictions on federally funded providers that contract with pharmacies to distribute discount drugs in the 340B drug discount program.

  • July 01, 2026

    4 Big Colorado Rulings So Far In 2026

    Insurance law took center stage in Colorado's appellate courts during the first half of 2026, but civil rights litigation produced its own notable mark on the landscape. Here, Law360 breaks down four major rulings in Colorado courts from the first half of 2026.

  • July 02, 2026

    CORRECTED: NJ Judge Keeps Ex-Executive's Bias Suit Alive

    A New Jersey state judge denied without prejudice the State Ethics Commission's bid to dismiss a former University Hospital executive's discrimination suit and rejected her cross‑motion for partial summary judgment, but reserved decision on the hospital's motion to toss portions of the case.

  • July 01, 2026

    Insurer Says COVID Test Co. Knew Of Theft Prior To Policy

    An insurer said it doesn't owe coverage to a COVID-19 test kit supplier for the purported theft of $106 million by its former directors and officers, telling a Nevada federal court that the alleged loss was first discovered a month before the commercial crime policy's inception.

  • July 01, 2026

    Mich. Judge Calls Ex-GM Worker Vexatious, Tosses Bias Suit

    A Michigan federal judge labeled a former General Motors employee a "vexatious litigator" in an opinion issued Tuesday after she filed "five separate lawsuits raising the same claims" against the same defendants and dismissed her workplace bias and harassment suit against General Motors Flint Assembly and UAW Local 598.

  • July 01, 2026

    Federal Judge Narrows Ex-DaVita Worker's Retaliation Suit

    A former dialysis worker lost her whistleblower claim against a DaVita Inc. unit on Wednesday, yet a Michigan federal judge allowed part of her wrongful discharge case to proceed, finding a jury could weigh whether she was fired after refusing to take part in conduct she believed was illegal. 

  • July 01, 2026

    Megadeals Driving Record M&A Values In Uneven 2026 Market

    Massive strategic transactions and technology deals pushed global M&A values in the first half of 2026 above the half-year peaks seen in the 2021 dealmaking boom, but experts say the market remains uneven and second-half expectations hinge on the absence of further geopolitical shocks.  

  • July 01, 2026

    Genesis Beats JV Partner's Challenge To $1B Sale In Ch. 11

    A Texas bankruptcy judge has rejected an objection to Genesis Healthcare's $1 billion sale of its 175 nursing homes, ruling that a joint venture partner cannot scuttle the deal by invoking a partnership agreement for a Maryland nursing home.

  • July 01, 2026

    Medical Marijuana Cos. Seek To Back DOJ In DC Circ.

    Two medical marijuana companies are seeking to intervene in a pending legal challenge to a U.S. Department of Justice final rule loosening federal restrictions on state-sanctioned medical cannabis, saying they would be harmed by the rule's rescission.

  • June 30, 2026

    Trump Public Loan Forgiveness Rule Is Unlawful, Judges Find

    Federal judges in Massachusetts and Washington, D.C., on Tuesday struck down a U.S. Department of Education rule that effectively narrowed which public service workers could receive student loan forgiveness, saying the department had issued limitations on qualifying employers outside its rulemaking authority.

  • June 30, 2026

    Health Attys Talk Cooperation In Gov't Fraud Investigations

    For attorneys defending healthcare clients hit with grand jury subpoenas and other enforcement actions investigating potential cases of fraud, cooperation with federal prosecutors is key.

  • June 30, 2026

    AIDS Group Says Cigna-Owned Express Scripts Hurts Patients

    AIDS Healthcare Foundation says its nonprofit wellness centers are going to be run out of business if Cigna-owned pharmacy benefit manager Express Scripts isn't stopped from using its muscle in the market to steer pharmacy patients toward specialty pharmacies it's affiliated with.

  • June 30, 2026

    Claims Full Of 'Fog' Cloud Pa. Nurse's Racial Bias Suit

    An employment lawsuit argued Tuesday in Pittsburgh could raise questions of a joint employer's obligation to investigate and oppose alleged racial bias by another employer, but a federal judge said the claims were obscured by "a bunch of fog" and sharply challenged the plaintiff's lawyer to state the case more clearly.

  • June 30, 2026

    Mental Health Nonprofit Hit With RN's Wage Suit Over Breaks

    A former Pine Rest Christian Mental Health Services registered nurse filed a proposed collective action on Tuesday accusing the Michigan health provider of shorting hourly workers on overtime pay through automatic meal-break deductions, time-rounding practices, unpaid training and excluded bonuses. 

  • June 30, 2026

    FDA Lets Zyn Market Some Pouches As Less Risky Than Cigs

    The U.S. Food and Drug Administration announced Tuesday that Philip Morris may now market 20 of its Zyn nicotine pouch products as having less of a health risk than cigarettes.

  • June 30, 2026

    Remedies, Not Suits: How FTC Approaches Health Mergers

    The Federal Trade Commission has not sued over any healthcare provider mergers since President Donald Trump's return to the White House. Attorneys at the American Health Law Association annual meeting say that's not a signal that the agency is backing off.

  • June 30, 2026

    Geico, Drivers Seek Final OK Of Deal Over Injury Coverage

    Geico and a class of hundreds of drivers asked a Washington federal court Tuesday to approve a settlement in a dispute over whether the insurer improperly withheld drivers' personal injury protection coverage by asserting they reached "maximum medical improvement."

  • June 30, 2026

    Patients Say Colo. Health Network Didn't Secure HIV Data

    A Colorado healthcare organization that operates as the state's largest source of services and programs for people impacted by HIV did not protect patients' private information in a cyberattack, according to three proposed class actions filed in state court.

  • June 30, 2026

    Pharma Co. Seeks Injunction Over Chinese Military Co. Label

    Chinese pharmaceutical company WuXi AppTec is urging a D.C. federal court judge to block the Pentagon from enforcing its designation of the company as a "Chinese military company," arguing the listing is unsupported by facts and was imposed without due process.

  • June 30, 2026

    Cigna, Others Fight Ohio AG's Drug Price-Fixing Suit

    Ohio pharmacy benefit managers and their corporate parents urged a federal judge to toss the state's drug price-fixing lawsuit, saying in a series of briefs that the state is trying to skirt federal pleading standards, collapse corporate separateness and stretch Ohio's antitrust law beyond its limits.

Expert Analysis

  • What Justices Are Focusing On In 'Skinny Label' Patent Case

    Author Photo

    Though Hikma v. Amarin appears to be a patent dispute that could reshape inducement doctrine in the pharmaceutical context, oral argument suggests the U.S. Supreme Court may treat this as primarily a pleading-stage dispute, with important unresolved questions lurking beneath the surface, says Shashank Upadhye at Upadhye Tang.

  • Accelerated Psychedelic Therapy Pathways Require Caution

    Author Photo

    President Donald Trump's new executive order aiming to accelerate the approval of psychedelic drugs for the treatment of mental health disorders will likely bolster investigational psychedelic therapies, but parties within the psychedelic product supply chain will still need to prepare for potentially burdensome compliance requirements, say attorneys at Morgan Lewis.

  • Heppner Ruling Left AI Privilege Risk For Lawyers Unresolved

    Author Photo

    While a New York federal judge’s recent ruling in U.S. v. Heppner resolved a privilege question surrounding client-side artificial intelligence use, it did not address how to mitigate the risks that can arise when confidential information enters the operative context of an AI system used by an attorney, says Jianfei Chen at Quarles & Brady​​​​​​​.

  • The Ethics And Practicalities Of Representing AI Agents

    Author Photo

    With autonomous artificial intelligence agents now able to take action without explicit instructions from — or the awareness of — their human owners, the bar must confront whether existing frameworks like informed consent and client privilege will be sufficient on the day an AI agent calls seeking counsel, say attorneys at Morrison Cohen.

  • Health Cos. Must Act Quickly To Secure Digital Front Doors

    Author Photo

    A fast-approaching deadline will require health providers to implement digital accessibility standards to their websites, necessitating important compliance steps that will help to ensure equal access to online health services, say attorneys at Holland & Knight.

  • Series

    Speed Jigsaw Puzzling Makes Me A Better Lawyer

    Author Photo

    My passion for speed puzzling — I can complete a 500-piece jigsaw puzzle in under 50 minutes — has sharpened my legal skills in more ways than one, with both disciplines requiring patience, precision and the ability to keep the bigger picture in mind while working through the details, says Tazia Statucki at Proskauer.

  • Documenting Business Purpose After IRS' 10th Circ. Win

    Author Photo

    Following the Tenth Circuit’s recent Liberty Global v. U.S. decision, which held the economic substance doctrine does not require a threshold relevancy determination, taxpayers can prepare for potential audits by maintaining contemporaneous documentation and taking other steps that demonstrate the business purpose of transactions, say attorneys at Crowell & Moring.

  • How Oregon Ruling Affects Federal Gender Care Crackdown

    Author Photo

    In a favorable development for healthcare providers, an Oregon federal court recently vacated certain U.S. Department of Health and Human Services restrictions on gender-affirming care for minors, but the government's broader campaign against this care, including proposed rulemaking and agency investigations, leaves significant uncertainty, say attorneys at Arnold & Porter.

  • Suit's Dismissal Would Not Settle Gold Card Visa's Legality

    Author Photo

    The government’s recent assertion that the plaintiffs in American Association of University Professors v. Department of Homeland Security lack standing to challenge the Trump administration’s pay-to-play immigration program does not address whether an agency can deem a million-dollar gift evidence of eligibility for immigration benefits carefully defined by Congress, says Jun Li at Reid & Wise.

  • 2 AI Snafus Show Why Attys Can't Outsource Judgment

    Author Photo

    The recent incident involving Sullivan & Cromwell where citations in a filed motion were fabricated by artificial intelligence, as well as a punitive ruling from the Sixth Circuit in U.S. v. Farris, demonstrate that the obligation to supervise AI has belonged and always will belong to lawyers, says John Powell at the Kentucky School Boards Association.

  • NY Opioid Antagonist Mandate Leaves Employers Guessing

    Author Photo

    A recently enacted New York law will require employers that are federally mandated to maintain first-aid supplies to now include an opioid antagonist, but being that it is subject to a complicated Occupational Safety and Health Administration analysis, employers face several unanswered compliance questions, say attorneys at Conn Maciel.

  • Calif. Case Raises Questions For Medical Practice Investors

    Author Photo

    The California attorney general's amicus brief in Art Center v. WCE and the California Medical Association's response highlight how the California appeals court's ruling could significantly affect the structure and enforceability of succession arrangements in medical practice ownership, say attorneys at Ropes & Gray.

  • Previewing FDA Preapproval Access In Psychedelics EO

    Author Photo

    The second of two pathways for psychedelic drug access outlined in President Donald Trump's recent executive order constitutes an unprecedented expansion of the Right to Try Act, which could fundamentally alter the psychedelic access landscape while presenting significant regulatory, operational and legal challenges, say attorneys at Husch Blackwell.

  • Previewing FDA National Priority Vouchers In Psychedelics EO

    Author Photo

    President Donald Trump's recent executive order on psychedelic drug access represents a watershed moment in federal drug policy, but its significance lies in two distinct regulatory pathways, the first being the Commissioner's National Priority Vouchers, which offer a significant opportunity to compress U.S. Food and Drug Administration review, say Kimberly Chew at Husch Blackwell and Odette Hauke at Odette Alina.

  • Series

    Playing Magic: The Gathering Makes Me A Better Lawyer

    Author Photo

    The competitive card game Magic: The Gathering offers me a training ground for the strategic thinking skills crucial to litigation, challenging me to adapt to oft-updated rules, analyze text as complicated as any statute and anticipate my opponent’s next moves, says Christopher Smith at Lash Goldberg.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.